Rapid detection of CAA/CAG repeat polymorphism in the AIB1 gene using DHPLC

Journal of Biochemical and Biophysical Methods

Volumn 70, Issue 3, 2007, Pages 511-513

  Kleibl, Zdenek ^a   Havranek, Ondrej ^a   Prokopcova, Jana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

AIB1; DHPLC; Polymorphism; Spreadex gel; Trinucleotide repeat

Indexed keywords

ADENINE; CYTOSINE; GUANINE; POLYGLUTAMINE;

AIB1 ONCOGENE; ANALYTIC METHOD; ARTICLE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

BASE SEQUENCE; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; DNA, NEOPLASM; FEMALE; HISTONE ACETYLTRANSFERASES; HUMANS; NUCLEIC ACID DENATURATION; POLYMORPHISM, GENETIC; TRANS-ACTIVATORS; TRINUCLEOTIDE REPEATS;

EID: 33847659222     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbbm.2006.11.011     Document Type: Article

References (15)

1. Weber B.L., and Nathanson K.L. Low penetrance genes associated with increased risk for breast cancer. Eur J Cancer 36 (2000) 1193-1199
2. Rebbeck T.R., Wang Y., Kantoff P.W., Krithivas K., Neuhausen S.L., Godwin A.K., et al. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 61 (2001) 5420-5424
3. Dai P., and Wong L.J. Somatic instability of the DNA sequences encoding the polymorphic polyglutamine tract of the AIB1 gene. J Med Genet 40 (2003) 885-890
4. Kadouri L., Kote-Jarai Z., Easton D.F., Hubert A., Hamoudi R., Glaser B., et al. Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BR CA1 carriers. Int J Cancer 108 (2004) 399-403
5. Hughes D.J., Ginolhac S.M., Coupier I., Barjhoux L., Gaborieau V., Bressac-de-Paillerets B., et al. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. Int J Cancer 117 (2005) 230-233
6. Wilkening S., Burwinkel B., Grzybowska E., Klaes R., Pamula J., Pekala W., et al. Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 291-292
7. Spurdle A.B., Antoniou A.C., Kelemen L., Holland H., Peock S., Cook M.R., et al. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 15 (2006) 76-79
8. Xiao W., and Oefner P.J. Denaturing high-performance liquid chromatography: a review. Hum Mutat 17 (2001) 439-474
9. Kosaki K., Udaka T., and Okuyama T. DHPLC in clinical molecular diagnostic services. Mol Genet Metab 86 (2005) 117-123
10. Frueh F.W., and Noyer-Weidner M. The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogenetics. Clin Chem Lab Med 41 (2003) 452-461
11. *1100delC in New York breast cancer cases and controls. BMC Med Genet 4 (2003) 1-4
12. Janatova M., Pohlreich P., and Matous B. Detection of the most frequent mutations in BRCA1 gene on polyacrylamide gels containing Spreadex Polymer NAB. Neoplasma 50 (2003) 246-250
13. Olejniczak M., and Krzyzosiak W.J. Genotyping of simple sequence repeat factors implicated in shadow band generation revisited. Electrophoresis 27 (2006) 3724-3734
14. Mulero J.J., Chang C.W., and Hennessy L.K. Characterization of the N+3 stutter product in the trinucleotide repeat locus DYS392. J. Forensic Sci 51 (2006) 1069-1073
15. Tran N., Bharaj B.S., Diamandis E.P., Smith M., Li B.D., and Yu H. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings. Cancer Epidemiol Biomarkers Prev 13 (2004) 2133-2140